Trials / Completed
CompletedNCT01159951
Analysis of Trends Over Time of Hepatitis Related Incidence in Panama
Time Trend Analysis of the Incidence of Hepatitis- Related Outcomes (Viral Hepatitis A and Unspecified Viral Hepatitis) Reported to the Surveillance System of Panama, 2000-2010
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to analyze the incidence of baseline hepatitis related outcomes (viral hepatitis A and unspecified viral hepatitis) together with the current frequency of the same outcome after introduction of Havrix™ in Panama.
Detailed description
In this study, systematic review of the databases of epidemiologic surveillance system (Ministry of Health), for hepatitis related outcomes will be performed. The analysis will be performed by age group, years and country region.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Epidemiologic Surveillance System of the Ministry of Health of Panama | Systematic review of the databases of epidemiologic surveillance system, Ministry of health, Panama |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2011-08-01
- Completion
- 2011-08-01
- First posted
- 2010-07-12
- Last updated
- 2017-06-07
Locations
1 site across 1 country: Panama
Source: ClinicalTrials.gov record NCT01159951. Inclusion in this directory is not an endorsement.